Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment
Mirella Georgouli(King's College London), Victoria Sanz‐Moreno(Queen Mary University of London), Cecilia Herráiz(Instituto Murciano de Investigación Biosanitaria), Silvia Mele(St Thomas' Hospital), Anna Perdrix(Queen Mary University of London), Frank O. Nestlé(Guy's and St Thomas' NHS Foundation Trust), Pahini Pandya(Institute of Cancer Research), Debra H. Josephs(Guy's and St Thomas' NHS Foundation Trust), Eva Crosas‐Molist(Institute of Cancer Research), Óscar Maiques(Institute of Cancer Research), Panagiotis Karagiannis(St Thomas' Hospital), José L. Orgaz(Queen Mary University of London), Ilaria Malanchi(The Francis Crick Institute), Sophia N. Karagiannis(King's College London), Xavier Matías‐Guiu(Universitat de Lleida), Kristina M. Ilieva(King's College London), Bruce Fanshawe(St Thomas' Hospital), Gilbert O. Fruhwirth(King's College London), Irene Rodríguez‐Hernández(Queen Mary University of London), Hoyin Lam(Hong Kong Sanatorium and Hospital), Gaia Cantelli(European Bioinformatics Institute)
Cited by 178
Related Papers
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
|Nature Genetics|2010|1.1k
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
|Nature Genetics|2012|1k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926
Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α
|The Journal of Experimental Medicine|2004|513